This statistic shows AstraZeneca's research & development expenditure as a percentage of its total revenue from 2006 to 2023. In 2023, the company invested 25 percent of its revenue into research and development. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Together with the Oxford University, the company also developed one of the first effective COVID-19 vaccines.
AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
AstraZeneca. (February 20, 2024). AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2023 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/266561/rundd-expenditure-of-astrazeneca-as-percentage-of-revenue-since-2006/
AstraZeneca. "AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2023." Chart. February 20, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/266561/rundd-expenditure-of-astrazeneca-as-percentage-of-revenue-since-2006/
AstraZeneca. (2024). AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2023. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/266561/rundd-expenditure-of-astrazeneca-as-percentage-of-revenue-since-2006/
AstraZeneca. "Astrazeneca's Research & Development Expenditure as a Percentage of Total Revenue from 2006 to 2023." Statista, Statista Inc., 20 Feb 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/266561/rundd-expenditure-of-astrazeneca-as-percentage-of-revenue-since-2006/
AstraZeneca, AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2023 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/266561/rundd-expenditure-of-astrazeneca-as-percentage-of-revenue-since-2006/ (last visited November 10, 2024)
AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2023 [Graph], AstraZeneca, February 20, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/266561/rundd-expenditure-of-astrazeneca-as-percentage-of-revenue-since-2006/